JOP20180089A1 - ): methods of treating pediatric cancers - Google Patents

): methods of treating pediatric cancers

Info

Publication number
JOP20180089A1
JOP20180089A1 JOP/2018/0089A JOP20180089A JOP20180089A1 JO P20180089 A1 JOP20180089 A1 JO P20180089A1 JO P20180089 A JOP20180089 A JO P20180089A JO P20180089 A1 JOP20180089 A1 JO P20180089A1
Authority
JO
Jordan
Prior art keywords
methods
pediatric cancers
treating pediatric
treating
subject
Prior art date
Application number
JOP/2018/0089A
Other languages
Arabic (ar)
Inventor
Michael Cox
Nisha Nanda
Steven A Smith
Mark Reynolds
Original Assignee
Loxo Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Loxo Oncology Inc filed Critical Loxo Oncology Inc
Priority to JOP/2018/0089A priority Critical patent/JOP20180089A1/en
Publication of JOP20180089A1 publication Critical patent/JOP20180089A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method of treating a pediatric cancer in a subject in need thereof. The method includes administering to the subject a therapeutically effective amount of (S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, or a pharmaceutically acceptable salt thereof, or a combination thereof.
JOP/2018/0089A 2018-10-02 2018-10-02 ): methods of treating pediatric cancers JOP20180089A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JOP/2018/0089A JOP20180089A1 (en) 2018-10-02 2018-10-02 ): methods of treating pediatric cancers

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JOP/2018/0089A JOP20180089A1 (en) 2018-10-02 2018-10-02 ): methods of treating pediatric cancers

Publications (1)

Publication Number Publication Date
JOP20180089A1 true JOP20180089A1 (en) 2020-04-02

Family

ID=75469096

Family Applications (1)

Application Number Title Priority Date Filing Date
JOP/2018/0089A JOP20180089A1 (en) 2018-10-02 2018-10-02 ): methods of treating pediatric cancers

Country Status (1)

Country Link
JO (1) JOP20180089A1 (en)

Similar Documents

Publication Publication Date Title
PH12018502134A1 (en) Methods of treating pediatric cancers
PH12018502124A1 (en) Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
MX2023008453A (en) Methods of treating substance abuse.
PH12021550809A1 (en) Crystalline form of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate
MX2022015695A (en) Camptothecin drug having high-stability hydrophilic connecting unit and conjugate thereof.
MX2014010590A (en) Combination therapy (vemrufenib and a mdm2 inhibitor) for the treatment proliferative disorders.
EP4353747A3 (en) Combination of zanubrutinib with an anti-cd20 or an anti-pd-1 antibody for use in treating cancer
MX2018001659A (en) Combination therapy using liposomal irinotecan and a parp inhibitor for cancer treatment.
WO2020102804A3 (en) Pharmaceutical combination for treatment of cancer
MX2019013643A (en) Combination therapy with 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,1 0-hexahydroimidazo[1,2-a]pyrido[4,3-d]pyrimidin-5(3h)-one.
MX2020008680A (en) Combination therapy with apilimod and glutamatergic agents.
MX2021002321A (en) Novel methods.
MX2022001863A (en) Ripretinib for treating gastrointestinal stromal tumors.
MX2021002322A (en) Novel methods.
WO2018102687A3 (en) Combination therapy for treating cancer
PH12018502422A1 (en) Nanoliposomal irinotecan for use in treating small cell lung cancer
MX2022006566A (en) Combination therapies for treatment of breast cancer.
PH12021551235A1 (en) Elacestrant in combination with abemaciclib in women with breast cancer
MX2021011289A (en) Compositions comprising pkm2 modulators and methods of treatment using the same.
JOP20210221A1 (en) Combination therapies for use in treating cancer
JOP20180089A1 (en) ): methods of treating pediatric cancers
MX2024003134A (en) Methods of cancer treatment using a combination of btk inhibitors and pi3 kinase inhibitors.
MX2022000729A (en) Combination therapy for cancer treatment.
MX2021007324A (en) Oral therapy using 6,8-bis-benzylthio-octanoic acid.
JOP20180088B1 (en) Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide